Dysregulation of neural calcium signaling in Alzheimer disease, bipolar disorder and schizophrenia

被引:164
作者
Berridge, Michael J. [1 ]
机构
[1] Babraham Inst, Cambridge, England
关键词
calcium; inositol trisphosphate; Alzheimer disease; schizophrenia; bipolar disease; reactive oxygen species; D-RECEPTOR GENE; VITAMIN-D; UP-REGULATION; MOUSE MODEL; PC12; CELLS; CA2+; LITHIUM; RELEASE; HOMEOSTASIS; ACTIVATION;
D O I
10.4161/pri.21767
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neurons have highly developed Ca2+ signaling systems responsible for regulating a large number of neural functions such as the control of brain rhythms, information processing and the changes in synaptic plasticity that underpin learning and memory. The tonic excitatory drive, which is activated by the ascending arousal system, is particularly important for processes such as sensory perception, cognition and consciousness. The Ca2+ signaling pathway is a key component of this arousal system that regulates the neuronal excitability responsible for controlling the neural brain rhythms required for information processing and cognition. Dysregulation of the Ca2+ signaling pathway responsible for many of these neuronal processes has been implicated in the development of some of the major neural diseases in man such as Alzheimer disease, bipolar disorder and schizophrenia. Various treatments, which are known to act by reducing the activity of Ca2+ signaling, have proved successful in alleviating the symptoms of some of these neural diseases.
引用
收藏
页码:2 / 13
页数:12
相关论文
共 85 条
[1]  
Amtul Z, 2012, NEUROBIOL AGING, V33, DOI [10.1016/j.neurobiolaging.2011.07.014, 10.1016/j.neurobiolaging.2011.12.038]
[2]  
Annweiler C, 2012, J GERONTO A IN PRESS
[3]   Possibility of a New Anti-Alzheimer's Disease Pharmaceutical Composition Combining Memantine and Vitamin D [J].
Annweiler, Cedric ;
Beauchet, Olivier .
DRUGS & AGING, 2012, 29 (02) :81-91
[4]   A genome-wide association study implicates diacylglycerol kinase η (DGKH) and several other genes in the etiology of bipolar disorder [J].
Baum, A. E. ;
Akula, N. ;
Cabanero, M. ;
Cardona, I. ;
Corona, W. ;
Klemens, B. ;
Schulze, T. G. ;
Cichon, S. ;
Rietschel, M. ;
Noethen, M. M. ;
Georgi, A. ;
Schumacher, J. ;
Schwarz, M. ;
Abou Jamra, R. ;
Hoefels, S. ;
Propping, P. ;
Satagopan, J. ;
Detera-Wadleigh, S. D. ;
Hardy, J. ;
McMahon, F. J. .
MOLECULAR PSYCHIATRY, 2008, 13 (02) :197-207
[5]   Does schizophrenia arise from oxidative dysregulation of parvalbumin-interneurons in the developing cortex? [J].
Behrens, M. Margarita ;
Sejnowski, Terrence J. .
NEUROPHARMACOLOGY, 2009, 57 (03) :193-200
[6]   Glutathione: a novel treatment target in psychiatry [J].
Berk, Michael ;
Ng, Felicity ;
Dean, Olivia ;
Dodd, Seetal ;
Bush, Ashley I. .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2008, 29 (07) :346-351
[7]   Calcium Signalling and Alzheimer's Disease [J].
Berridge, Michael J. .
NEUROCHEMICAL RESEARCH, 2011, 36 (07) :1149-1156
[8]   Calcium hypothesis of Alzheimer's disease [J].
Berridge, Michael J. .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2010, 459 (03) :441-449
[9]   NEURAL AND DEVELOPMENTAL ACTIONS OF LITHIUM - A UNIFYING HYPOTHESIS [J].
BERRIDGE, MJ ;
DOWNES, CP ;
HANLEY, MR .
CELL, 1989, 59 (03) :411-419
[10]   Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease [J].
Bezprozvanny, Ilya ;
Mattson, Mark P. .
TRENDS IN NEUROSCIENCES, 2008, 31 (09) :454-463